Protective effects of calcitonin gene-related peptide in different experimental models of gastric ulcers.
Intravenous administration of calcitonin gene-related peptide (CGRP) prevented in a dose-dependent manner reserpine-induced gastric mucosal damage, but failed to affect the lesions produced by ethanol administration. In pylorus-ligated rats, CGRP significantly reduced gastric volume, total acid and peptic activity output as well as ulcer formation. These protective effects of CGRP were not present when rats were pretreated with cysteamine. Our data suggest that CGRP exerts its antisecretory and antiulcer activity, at least in part, by interfering with somatostatin transmission.
Clementi
G
G
Institute of Pharmacology, University of Catania School of Medicine, Italy.
Amico-Roxas
M
M
Caruso
A
A
Cutuli
V M
VM
Maugeri
S
S
Prato
A
A
D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003543:Cysteamine / Q000494:pharmacology; D000431:Ethanol / Q000633:toxicity; D005744:Gastric Acid / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects*; D007275:Injections, Intravenous; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012110:Reserpine / Q000633:toxicity; D013276:Stomach Ulcer / Q000139:chemically induced / Q000188:drug therapy*
D000431:Ethanol; D003543:Cysteamine; D012110:Reserpine; D015740:Calcitonin Gene-Related Peptide